Profil
Niall M.
B. Martin is the founder of MISSION Therapeutics Ltd. (2011), holding the title of Executive Vice President-Discovery.
Dr. Martin was the founder of Artios Pharma Ltd. (2016), holding the title of Chief Executive Officer & Director from 2016 to 2025.
Former job includes Director-Drug Discovery at KuDOS Pharmaceuticals Ltd. from 1999 to 2010.
Education includes a doctorate from the University of Aberdeen.
Anciens postes connus de Niall M. B. Martin
| Sociétés | Poste | Fin |
|---|---|---|
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Fondateur | 12/08/2025 |
KuDOS Pharmaceuticals Ltd.
KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products | Corporate Officer/Principal | - |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Fondateur | - |
Formation de Niall M. B. Martin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KuDOS Pharmaceuticals Ltd.
KuDOS Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products | Health Technology |
MISSION Therapeutics Ltd.
MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs targeting enzymes involved in cancer and other diseases | Health Technology |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
















